Gilbert Mbeo, MD
Interventional Pain Medicine · Orlando, FLNPI 1396024949
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,885 of the $5,845 with a category attached, or 83.6%. It is spread thinly across 42 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations.
Across 146 payments — averaging $40.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$860
- Boston Scientific$780
- AbbVie$652
- Nevro Corp.$566
- Novartis$489
- Takeda Pharmaceuticals U.S.A., Inc.$443
- plus $2K from 36 others
Across 16 payments — averaging $85,635 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$658K
- E.r. Squibb & Sons, L.L.C.$401K
- Eli Lilly$221K
- Novartis$74K
- Genentech, Inc.$17K
What the payments were for
- Speaking & faculty fees$882%
- Travel & lodging$87215%
- Food & beverage$4,88584%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 11 | $860 |
| Boston Scientific | 5 | $780 |
| AbbVie | 30 | $652 |
| Nevro Corp. | 11 | $566 |
| Novartis | 4 | $489 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $443 |
| Vertos Medical, Inc. | 2 | $179 |
| SPR Therapeutics, Inc | 6 | $162 |
| Axogen | 1 | $142 |
| Novocure Inc. | 1 | $130 |
| Pfizer | 5 | $127 |
| Pacira Pharmaceuticals Incorporated | 4 | $96 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Eisai Inc. | 4 | $89 |
| Irras USA, Inc. | 1 | $88 |
| F. Hoffmann-la Roche AG | 1 | $80 |
| GRT US Holding, Inc. | 3 | $79 |
| Curonix LLC | 4 | $65 |
| Amneal Pharmaceuticals LLC | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Averitas Pharma Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $44 |
| Genentech USA, Inc. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Biogen | 2 | $37 |
| Ceribell, Inc. | 1 | $36 |
| Neurelis, Inc. | 2 | $36 |
| Vertex | 1 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Abbott | 1 | $30 |
| Nalu Medical, Inc. | 1 | $27 |
| Argenx US, Inc. | 1 | $27 |
| Avanos Medical | 1 | $26 |
| Brainsway USA Inc | 1 | $24 |
| CSL Behring | 1 | $21 |
| Painteq LLC | 1 | $20 |
| Saluda Medical Americas, Inc. | 1 | $19 |
| Merck | 1 | $19 |
| Xtant Medical Inc | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Portola Pharmaceuticals, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,845 in reported general payments places this provider in the 55th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 13 | $1,391 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $853 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $605 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 27 | $520 |
| Oxycodone Hcl | 13 | $275 |
| Meloxicam | 45 | $200 |
| Pregabalin | 19 | $160 |
| Gabapentin | 15 | $139 |
| Nortriptyline Hcl | 15 | $117 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Orlando
- Richard GaylesOrlando$14K
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
- Giuseppe PaeseBoca Raton$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.